SCHEMBL1767768

SCHEMBL1767768

CC(C)(C)Cc1cc(C#C[Si](C)(C)C)ncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21325539 0.75 GRN (0.32)
SCHEMBL30600692 0.71 OGA (0.34)
SCHEMBL31546684 0.70 CYP2C19 (0.39)
SCHEMBL31546704 0.70 CYP2C19 (0.39)
SCHEMBL20165962 0.69 NPC1 (0.30)
SCHEMBL1767744 0.69 AAK1 (0.31)
SCHEMBL18501678 0.67
SCHEMBL1767766 0.67 GRN (0.31)
SCHEMBL25025259 0.66 CYP2C19 (0.38)
SCHEMBL21350605 0.65 NOS3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822485-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2014-09-02 US disclosed
US-20130018064-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2013-01-17 US disclosed
EP-2504330-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063272-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed